Magnolia Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Sell |
17,325
-351
| -2% | -$30.6K | 0.38% | 77 |
|
|
2025
Q1 | $1.59M | Buy |
17,676
+662
| +4% | +$59.5K | 0.43% | 61 |
|
|
2024
Q4 | $1.36M | Buy |
17,014
+3,481
| +26% | +$278K | 0.35% | 76 |
|
|
2024
Q3 | $1.22M | Buy |
13,533
+1,330
| +11% | +$120K | 0.61% | 47 |
|
|
2024
Q2 | $960K | Buy |
+12,203
| New | +$960K | 0.54% | 53 |
|
|
2023
Q3 | – | Sell |
-11,911
| Closed | -$1.05M | – | 115 |
|
|
2023
Q2 | $1.05M | Sell |
11,911
-30
| -0.3% | -$2.64K | 0.53% | 58 |
|
|
2023
Q1 | $963K | Buy |
11,941
+1,503
| +14% | +$121K | 0.5% | 57 |
|
|
2022
Q4 | $811K | Buy |
10,438
+20
| +0.2% | +$1.55K | 0.54% | 55 |
|
|
2022
Q3 | $841K | Sell |
10,418
-10
| -0.1% | -$807 | 0.71% | 49 |
|
|
2022
Q2 | $935K | Sell |
10,428
-437
| -4% | -$39.2K | 0.85% | 43 |
|
|
2022
Q1 | $1.21M | Buy |
10,865
+266
| +3% | +$29.5K | 0.47% | 65 |
|
|
2021
Q4 | $1.1M | Buy |
10,599
+538
| +5% | +$55.6K | 0.32% | 71 |
|
|
2021
Q3 | $1.26M | Buy |
10,061
+699
| +7% | +$87.7K | 0.44% | 61 |
|
|
2021
Q2 | $1.16M | Buy |
9,362
+847
| +10% | +$105K | 0.51% | 48 |
|
|
2021
Q1 | $1.01M | Buy |
8,515
+5,786
| +212% | +$684K | 1.99% | 15 |
|
|
2020
Q4 | $320K | Buy |
2,729
+104
| +4% | +$12.2K | 0.21% | 81 |
|
|
2020
Q3 | $273K | Sell |
2,625
-89
| -3% | -$9.26K | 0.21% | 76 |
|
|
2020
Q2 | $249K | Sell |
2,714
-308
| -10% | -$28.3K | 0.32% | 76 |
|
|
2020
Q1 | $273K | Buy |
3,022
+104
| +4% | +$9.4K | 0.53% | 46 |
|
|
2019
Q4 | $331K | Buy |
+2,918
| New | +$331K | 0.32% | 54 |
|